Supplement epidiferphane aims to ease Chemo's harsh side effects

NCT ID NCT05074290

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a nutritional supplement called Epidiferphane can reduce common side effects of taxane chemotherapy, such as nerve damage and anemia, in breast cancer patients. About 74 participants will receive Epidiferphane alongside their standard chemo to see if it helps them stay on full-dose treatment and improves tumor response. The study also checks the supplement's safety and maximum tolerated dose.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32608, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.